279 related articles for article (PubMed ID: 11959198)
1. Simple tacrolimus-based immunosuppressive regimens following renal transplantation: a large multicenter comparison between double and triple therapy.
Pascual J; Ortuño J;
Transplant Proc; 2002 Feb; 34(1):89-91. PubMed ID: 11959198
[No Abstract] [Full Text] [Related]
2. One-year follow-up of a large European trial comparing dual versus triple tacrolimus-based immunosuppressive regimens following renal transplantation.
Calconi G; Vianello A;
Transplant Proc; 2001; 33(1-2):1021-4. PubMed ID: 11267173
[No Abstract] [Full Text] [Related]
3. Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group.
Forsythe J
Transplant Proc; 1999 Nov; 31(7A):69S-71S. PubMed ID: 10576049
[No Abstract] [Full Text] [Related]
4. Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.
Sola E; Alférez MJ; Cabello M; Burgos D; González Molina M
Transplant Proc; 2002 Aug; 34(5):1689-90. PubMed ID: 12176537
[No Abstract] [Full Text] [Related]
5. Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid.
Morales JM; Andrés A; Morales E; Herrero JC; Cubas A; Praga M; Hernández E; Ortuño T; Dominguez-Gil B; Carreño A; Delgado M; Manzanares C
Transplant Proc; 1999 Nov; 31(7A):75S-77S. PubMed ID: 10576051
[No Abstract] [Full Text] [Related]
6. Tacrolimus versus cyclosporine as primary prophylactic therapy after cadaveric renal transplant: two-year survival study.
Wong KM; Cheung CY; Chan YH; Chak WL; Choi KS; Chau KF; Li CS
Transplant Proc; 2000 Nov; 32(7):1721-2. PubMed ID: 11119907
[No Abstract] [Full Text] [Related]
7. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
[No Abstract] [Full Text] [Related]
8. Pediatric renal transplantation under tacrolimus-based immunosuppression.
Shapiro R; Scantlebury VP; Jordan ML; Vivas C; Ellis D; Lombardozzi-Lane S; Gilboa N; Gritsch HA; Irish W; McCauley J; Fung JJ; Hakala TR; Simmons RL; Starzl TE
Transplantation; 1999 Jan; 67(2):299-303. PubMed ID: 10075598
[TBL] [Abstract][Full Text] [Related]
9. Comparison between a two-drug regimen with tacrolimus and steroids and a triple one with azathioprine in kidney transplantation: results of a European trial with 3-year follow up.
Pascual J; Segoloni G; Gonzalez Molina M; del Castillo D; Capdevila L; Arias M; Garcia J; Ortuño J;
Transplant Proc; 2003 Aug; 35(5):1701-3. PubMed ID: 12962764
[TBL] [Abstract][Full Text] [Related]
10. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
Jurewicz WA
Transplant Proc; 1999 Nov; 31(7A):64S-66S. PubMed ID: 10576048
[No Abstract] [Full Text] [Related]
11. Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
Krämer BK; Klinger M; Vítko Š; Glyda M; Midtvedt K; Stefoni S; Citterio F; Pietruck F; Squifflet JP; Segoloni G; Krüger B; Sperschneider H; Banas B; Bäckman L; Weber M; Carmellini M; Perner F; Claesson K; Marcinkowski W; Ostrowski M; Senatorski G; Nordström J; Salmela K
Transplantation; 2012 Sep; 94(5):492-8. PubMed ID: 22858806
[TBL] [Abstract][Full Text] [Related]
12. Outcome after steroid withdrawal in renal transplant patients receiving tacrolimus-based immunosuppression.
Shapiro R; Jordan ML; Scantlebury VP; Vivas C; Gritsch HA; McCauley J; McQuitty D; Randhawa P; Irish W; McMichael J; Hakala TR; Simmons RL; Fung JJ; Starzl TE
Transplant Proc; 1998 Jun; 30(4):1375-7. PubMed ID: 9636557
[No Abstract] [Full Text] [Related]
13. Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: two-year follow-up.
Garcia I;
Transplant Proc; 2002 Aug; 34(5):1638-9. PubMed ID: 12176516
[No Abstract] [Full Text] [Related]
14. Current advantage of FK 506 in cadaveric kidney transplantation.
Ciancio G; Rosen A; Loreto-Grand B; Burke G; Siquijor A; Luque C; Esquenazi V; Miller J
Transplant Proc; 1996 Apr; 28(2):1000-1. PubMed ID: 8623207
[No Abstract] [Full Text] [Related]
15. Steroids withdrawal after 3 months of successful renal transplantation using a tacrolimus- and mycophenolate-based immunosuppression.
Alarcón-Zurita A; Munar MA; Losada P; Morey A; Martinez J; de la Prada FJ; Marco J
Transplant Proc; 2002 Feb; 34(1):118-9. PubMed ID: 11959216
[No Abstract] [Full Text] [Related]
16. Long-term comparison of tacrolimus and cyclosporine-based immunosuppression in kidney recipients with grafts from non-heart-beating cadaver donor.
Kinukawa T; Ohshima S; Ono Y; Fujita T; Hattori R; Tanaka K
Transplant Proc; 1998 Jun; 30(4):1227-9. PubMed ID: 9636498
[No Abstract] [Full Text] [Related]
17. Induction versus non-induction protocols in anti-calcineurin-based immunosuppression.
Charpentier B
Transplant Proc; 2001; 33(7-8):3334-6. PubMed ID: 11750425
[No Abstract] [Full Text] [Related]
18. One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation.
Campos HH; Abbud Filho M;
Transplant Proc; 2002 Aug; 34(5):1656-8. PubMed ID: 12176523
[No Abstract] [Full Text] [Related]
19. Long-term results of living kidney transplantation under tacrolimus immunosuppression: a single-center experience.
Tanabe K; Ishikawa N; Tokumoto T; Takahashi K; Kanematsu A; Kitani R; Fuchinoue S; Oshima T; Yagisawa T; Toma H
Transplant Proc; 1998 Jun; 30(4):1224-6. PubMed ID: 9636497
[No Abstract] [Full Text] [Related]
20. 36-month follow-up of 75 renal allograft recipients treated with steroids, tacrolimus, and azathioprine or mycophenolate mofetil.
Mucha K; Foroncewicz B; Paczek L; Pazik J; Lewandowska D; Krawczyk A; Pliszczynski J; Gradowska L; Durlik M; Walaszewski J; Nazarewski S; Szmidt J
Transplant Proc; 2003 Sep; 35(6):2176-8. PubMed ID: 14529880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
